Back to search
Living Donors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Living Donors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Living Donors trials you may qualify forThe purpose of this study is to find out if an investigational treatment will allow kidney transplant recipients to better accept their new kidney and stop immu…
The goal of this feasibility clinical trial is to learn if telemedicine can be used to provide education and evaluation and counseling for people who are consid…
Monocentre, non-randomized, non-blinded, open-label interventional study to identification of relevant changes in molecular biology in proteome, phosphoproteome…
The goal of this clinical trial is to compare the effects of somatostatin and terlipressin on lowering portal pressure in patients with portal hypertension unde…
The only curative treatment for end-stage renal disease is through kidney transplantation. Solid organ transplants success had been made possible by the develop…
The goal of this multi-national, multi-center, open-label, randomized Phase 2 trial is to determine the safety and efficacy of administering expanded regulatory…
As the only curative treatment for end-stage liver diseases, liver transplantation has been widely carried out around the world. The shortage of organs from dec…
Anxiety is a state of worry and apprehension caused by internal and external threats. High preoperative anxiety levels have been associated with increased anest…
Cardiovascular disease remains one of the major cause of mortality in renal transplant recipients, with the rate of cardiac death 10-times higher than that of t…